Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Revenue

Kiniksa Pharmaceuticals International, had revenue of $214.27M in the quarter ending March 31, 2026, with 55.51% growth. This brings the company's revenue in the last twelve months to $754.05M, up 56.71% year-over-year. In the year 2025, Kiniksa Pharmaceuticals International, had annual revenue of $677.56M with 60.09% growth.

• Revenue (ttm): $754.05M
• Revenue Growth: +56.71%
• P/S Ratio: 6.10
• Revenue / Employee: $2,060,232
• Employees: 366
• Market Cap: 4.52B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	677.56M	254.33M	60.09%
Dec 31, 2024	423.24M	152.98M	56.60%
Dec 31, 2023	270.26M	50.08M	22.74%
Dec 31, 2022	220.18M	181.64M	471.24%
Dec 31, 2021	38.54M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error